The Effectiveness of Probiotics in Treating Food and Cow's Milk Allergies among Pediatric Age Group: A Meta-analysis of Randomized Controlled Trials.

Iranian journal of allergy, asthma, and immunology. 2023;22(2):124-137

Plain language summary

Food allergy is defined as any adverse health effect that occurs due to a specific immune response that usually repeats every time after a specific food exposure. The aim of this study was to determine the effectiveness of administering probiotics as a supplement to treat food and cow’s milk allergies among children less than 5 years old as compared to placebo. This study was a systematic review and meta-analysis of twenty randomised controlled trials. Results showed that probiotic supplementation significantly improved food allergy symptoms when compared to a placebo. Furthermore, subgroup analysis also revealed that the effect remained favourable in all subgroups. Authors concluded that probiotics may be useful in reducing food allergies among children under 5. However, they also point out that more systematic reviews are needed to assess the safety and side effect pattern of these probiotics.

Abstract

The global prevalence of allergies is on the rise. Food allergies are of special concern among children under 5 years of age, leading to morbidity and mortality. Though the standard management is avoidance, probiotics are being used widely to prevent and treat food allergies. We aimed to determine the effect of probiotics as a therapeutic option for controlling food and cow's milk allergy among children under 5 years of age. A systematic search of electronic medical literature databases was conducted. We included all eligible randomized controlled trials available from inception until May 2021. The primary outcome of interest was the relief of allergic symptoms, while the secondary outcome was the induction of tolerance. Two investigators undertook the literature search, screening, data extraction, and quality appraisal independently. Data analysis and synthesis were performed using STATA 14 software. Subgroup analysis was performed for the duration of use and follow-up, and the age category of children included in the outcome were done. Twenty trials involving 4043 pediatric patients with food allergies were included in the review. Subgroup analysis also revealed that probiotics were effective in treating food allergies across the various subgroups included in the model. Around 15 trials reported our primary outcome, relief of symptoms, as a binary variable, which was pooled to obtain a risk ratio of 0.86 (95% confidence interval [CI], 0.77-0.95), with very low heterogeneity (I2 7.7%). Six trials were included for the secondary outcome of interest, which gave an imprecise pooled estimate of 1.29 (95% CI, 0.98-1.70) with significant heterogeneity (I2 7). Thus, we conclude that probiotics can serve as a vital therapeutic option in tackling food allergies among children less than 5 years of age. Further larger studies exploring the effectiveness of individual strains and their safety pattern are essential.

Lifestyle medicine

Patient Centred Factors : Mediators/Allergies
Environmental Inputs : Diet ; Microorganisms
Personal Lifestyle Factors : Nutrition
Functional Laboratory Testing : Not applicable
Bioactive Substances : Probiotics

Methodological quality

Jadad score : Not applicable
Allocation concealment : Not applicable
Publication Type : Journal Article ; Meta-Analysis

Metadata

Nutrition Evidence keywords : Probiotics ; Allergies ; Paediatric ; Allergen